Zobrazeno 1 - 10
of 128
pro vyhledávání: '"de Vera Mudry MC"'
Autor:
Patel S; School of Microbiology and APC Microbiome Ireland, University College Cork, Cork, Ireland.; SeqBiome Ltd, Cork, Ireland., Becker E; Pharmaceutical Sciences, Roche Innovation Center Basel, Pharma Research & Early Development, Hoffmann-La Roche, Basel, Switzerland., Ploix C; Pharmaceutical Sciences, Roche Innovation Center Basel, Pharma Research & Early Development, Hoffmann-La Roche, Basel, Switzerland., Steiner G; Pharmaceutical Sciences, Roche Innovation Center Basel, Pharma Research & Early Development, Hoffmann-La Roche, Basel, Switzerland., Scepanovic P; Pharmaceutical Sciences, Roche Innovation Center Basel, Pharma Research & Early Development, Hoffmann-La Roche, Basel, Switzerland., Fueth M; Pharmaceutical Sciences, Roche Innovation Center Basel, Pharma Research & Early Development, Hoffmann-La Roche, Basel, Switzerland., de Vera Mudry MC; Pharmaceutical Sciences, Roche Innovation Center Basel, Pharma Research & Early Development, Hoffmann-La Roche, Basel, Switzerland., Eichinger-Chapelon A; Pharmaceutical Sciences, Roche Innovation Center Basel, Pharma Research & Early Development, Hoffmann-La Roche, Basel, Switzerland., Marrer-Berger E; Pharmaceutical Sciences, Roche Innovation Center Basel, Pharma Research & Early Development, Hoffmann-La Roche, Basel, Switzerland., Claesson MJ; School of Microbiology and APC Microbiome Ireland, University College Cork, Cork, Ireland.; SeqBiome Ltd, Cork, Ireland.
Publikováno v:
ImmunoHorizons [Immunohorizons] 2023 Dec 01; Vol. 7 (12), pp. 872-885.
Autor:
Wildum S; Roche Pharma, Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Korolowicz KE; Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United States., Suresh M; Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United States., Steiner G; Roche Pharma, Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Dai L; Roche Pharma, Research and Early Development, Roche Innovation Center Shanghai, Shanghai, China., Li B; Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United States., Yon C; Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United States., De Vera Mudry MC; Roche Pharma, Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Regenass-Lechner F; Roche Pharma, Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Huang X; Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United States., Hong X; Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United States., Murreddu MG; Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United States., Kallakury BV; Department of Pathology, Georgetown University Medical Center, Washington, DC, United States., Young JAT; Roche Pharma, Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Menne S; Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 May 23; Vol. 13, pp. 884113. Date of Electronic Publication: 2022 May 23 (Print Publication: 2022).
Autor:
De Vera Mudry MC; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 1529F. Hoffmann-La Roche Ltd, Basel, Switzerland., Martin J; 1529Roche Tissue Diagnostics, Santa Clara, CA, USA., Schumacher V; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 1529F. Hoffmann-La Roche Ltd, Basel, Switzerland., Venugopal R; 1529Roche Tissue Diagnostics, Santa Clara, CA, USA.
Publikováno v:
Toxicologic pathology [Toxicol Pathol] 2021 Jun; Vol. 49 (4), pp. 851-861. Date of Electronic Publication: 2020 Dec 29.
Autor:
Parrula C; Preclinical Safety Evaluation, 2184Vertex Pharmaceuticals Incorporated, Boston, MA, USA., Dincer Z; Pathology, 63899Covance Laboratories Limited, Harrogate, United Kingdom., Geoly FJ; 105623Worldwide Research & Development, Pfizer Inc, Groton, CT, USA., De Vera Mudry MC; 1529Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Mysore J; Drug Safety Evaluation, 3971Bristol-Myers Squibb, New Brunswick, NJ, USA., Wuersch K; PreClinical Safety, 98560Novartis AG, Basel, Switzerland.
Publikováno v:
Toxicologic pathology [Toxicol Pathol] 2020 Dec; Vol. 48 (8), pp. 939-943. Date of Electronic Publication: 2020 Nov 28.
Autor:
Lucas, Robert J.1 (AUTHOR) robert.lucas@manchester.ac.uk, Allen, Annette E.1 (AUTHOR), Brainard, George C.2 (AUTHOR), Brown, Timothy M.1 (AUTHOR), Dauchy, Robert T.3 (AUTHOR), Didikoglu, Altug4 (AUTHOR), Do, Michael Tri H.5 (AUTHOR), Gaskill, Brianna N.6 (AUTHOR), Hattar, Samer7 (AUTHOR), Hawkins, Penny8 (AUTHOR), Hut, Roelof A.9 (AUTHOR), McDowell, Richard J.1 (AUTHOR), Nelson, Randy J.10 (AUTHOR), Prins, Jan-Bas11,12 (AUTHOR), Schmidt, Tiffany M.13 (AUTHOR), Takahashi, Joseph S.14,15 (AUTHOR), Verma, Vandana16 (AUTHOR), Voikar, Vootele17 (AUTHOR), Wells, Sara18 (AUTHOR), Peirson, Stuart N.19 (AUTHOR) robert.lucas@manchester.ac.uk
Publikováno v:
PLoS Biology. 3/12/2024, Vol. 22 Issue 3, p1-24. 24p.
Autor:
Klein C; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Waldhauer I; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Nicolini VG; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Freimoser-Grundschober A; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Nayak T; Roche Pharma Research & Early Development, Roche Innovation Center Basel , Basel, Switzerland., Vugts DJ; Roche Pharma Research & Early Development, Department of Radiology & Nuclear Medicine, VU University Medical Center , Amsterdam, the Netherlands., Dunn C; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Bolijn M; Roche Pharma Research & Early Development, Department of Radiology & Nuclear Medicine, VU University Medical Center , Amsterdam, the Netherlands., Benz J; Roche Pharma Research & Early Development, Roche Innovation Center Basel , Basel, Switzerland., Stihle M; Roche Pharma Research & Early Development, Roche Innovation Center Basel , Basel, Switzerland., Lang S; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Roemmele M; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Hofer T; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., van Puijenbroek E; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Wittig D; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Moser S; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Ast O; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Brünker P; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Gorr IH; Roche Pharma Research & Early Development, Roche Innovation Center Munich , Penzberg, Germany., Neumann S; Roche Pharma Research & Early Development, Roche Innovation Center Basel , Basel, Switzerland., de Vera Mudry MC; Roche Pharma Research & Early Development, Roche Innovation Center Basel , Basel, Switzerland., Hinton H; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Crameri F; Roche Pharma Research & Early Development, Roche Innovation Center Basel , Basel, Switzerland., Saro J; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Evers S; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Gerdes C; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Bacac M; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., van Dongen G; Roche Pharma Research & Early Development, Department of Radiology & Nuclear Medicine, VU University Medical Center , Amsterdam, the Netherlands., Moessner E; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Umaña P; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2017 Jan 11; Vol. 6 (3), pp. e1277306. Date of Electronic Publication: 2017 Jan 11 (Print Publication: 2017).
Autor:
Bogman K; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B). katrijn.bogman@roche.com., Schwab D; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B)., Delporte ML; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B)., Palermo G; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B)., Amrein K; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B)., Mohr S; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B)., De Vera Mudry MC; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B)., Brown MJ; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B)., Ferber P; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B).
Publikováno v:
Hypertension (Dallas, Tex. : 1979) [Hypertension] 2017 Jan; Vol. 69 (1), pp. 189-196. Date of Electronic Publication: 2016 Nov 21.
Autor:
Bessa J; F. Hoffmann-La Roche Ltd, pRED, Pharma Research and Early Development, Grenzacherstrasse 124, CH-4070 Basel, Switzerland., Meyer CA; F. Hoffmann-La Roche Ltd, pRED, Pharma Research and Early Development, Grenzacherstrasse 124, CH-4070 Basel, Switzerland., de Vera Mudry MC; F. Hoffmann-La Roche Ltd, pRED, Pharma Research and Early Development, Grenzacherstrasse 124, CH-4070 Basel, Switzerland., Schlicht S; F. Hoffmann-La Roche Ltd, pRED, Pharma Research and Early Development, Grenzacherstrasse 124, CH-4070 Basel, Switzerland., Smith SH; Stiefel, a GSK Company, Center for Skin Biology, 20 T.W. Alexander Dr., Research Triangle Park, NC 27709, USA., Iglesias A; F. Hoffmann-La Roche Ltd, pRED, Pharma Research and Early Development, Grenzacherstrasse 124, CH-4070 Basel, Switzerland., Cote-Sierra J; Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, NJ, USA. Electronic address: Javier.x.cote-sierra@stiefel.com.
Publikováno v:
Journal of autoimmunity [J Autoimmun] 2014 Dec; Vol. 55, pp. 33-41. Date of Electronic Publication: 2014 Apr 29.
Autor:
De Vera Mudry MC; Department of Non-Clinical Drug Safety, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Kronenberg S, Komatsu S, Aguirre GD
Publikováno v:
Toxicologic pathology [Toxicol Pathol] 2013 Aug; Vol. 41 (6), pp. 813-25. Date of Electronic Publication: 2012 Dec 27.
Autor:
de Vera Mudry MC; Non-Clinical Safety, Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland., Regenass-Lechner F, Ozmen L, Altmann B, Festag M, Singer T, Müller L, Jacobsen H, Flohr A
Publikováno v:
International journal of Alzheimer's disease [Int J Alzheimers Dis] 2012; Vol. 2012, pp. 289412. Date of Electronic Publication: 2012 Dec 17.